Veterinary CRO Market Measurement to Attain $1.26 Bn, Globally, by 2027 at 7.7% CAGR: Allied Market Analysis

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Portland, OR, April 8, 2021 (GLOBE NEWSWIRE) – Allied Market Research released a report entitled: Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Marketing Authorization and Regulatory Support, etc.), Application (Dogs, Cats, and Others), and End-Users (Oncology, Infectious Diseases, Neurology, and Others): Global Opportunity Analysis and Industry Forecast, 2020– 2027. “ According to the report, the global veterinary CRO industry generated $ 771.8 million in 2019 and is estimated at $ 1.26 billion in 2027, an annual growth rate of 7.7% from 2020 to 2027.

Download the detailed COVID-19 Impact Sample Report from:

Driver, Restrictions and Opportunities

The increase in pet ownership, the rise in animal health spending, and the prevalence of pet disease are driving the growth of the global Veterinary CRO market. However, a lack of standardization among veterinary CROs is hindering market growth. On the other hand, raising awareness of animal health offers new opportunities in the years to come.

Covid-19 scenario

  • Most practices in the animal health industry have been affected due to transportation restrictions, limited human resources and statewide lockdowns during the Covid-19 pandemic.
  • There was an economic slowdown due to the pandemic. This placed restrictions on the funding of R&D activities for veterinary companies and they had to outsource these activities.
  • Research and development activities for the development of Covid-19 veterinary vaccines and antiviral drugs have increased significantly as several cases of infections in dogs and cats have been reported.

The clinical trials segment is expected to maintain its leadership status over the forecast period

Based on service type, the clinical trials segment contributed the largest market share, holding nearly a third of the global veterinary CRO market in 2019. It will retain its leadership status in the forecast period. In addition, the highest CAGR of 8.5% is forecast for this segment from 2020 to 2027. This is due to the amount of time it takes to complete the clinical trial process, which encourages the outsourcing of the service. The report also provides detailed analysis of segments including toxicology, regulatory and regulatory support, and others.

For a purchase request to:

The dog segment should maintain its dominant share throughout the forecast period

In terms of animal type, the dog segment had the highest share of sales in 2019, contributing to more than two-fifths of the global veterinary CRO market. It is estimated that it will maintain its dominant share over the forecast period. In addition, this segment is expected to grow from 2020 to 2027 with the highest CAGR of 8.3%. This is due to the increasing use of dogs as companion animals around the world. The study also analyzes segments like cats and others.

North America is expected to maintain its leadership position through 2027

In terms of region, North America had the largest market share in 2019 with more than a third of the global veterinary CRO market and will maintain its leading position through 2027. This is due to the ready availability of CRO products, pet ownership and increased animal health spending. However, the Asia-Pacific region is projected to have the highest CAGR of 8.9% over the forecast period as animal health awareness has risen in the population.

Leading market players

  • Charles River Laboratories, Inc.
  • Clinvet
  • Oncovet Clinical Research
  • Löhlein & Wolf veterinary research
  • Triveritas
  • ONDAX Scientific
  • VetPharm, Inc.
  • Veterinary Research Management (VRM) Ltd.

Avenue ground plan | Library access | 1 year subscription |

Sign up for the Avenue subscription to access 12,000+ company profiles and 2,000+ market research reports in the niche industry at a cost of $ 699 per month per seat. The customer must purchase at least 2 seats for one year.

Avenue Library Subscription | Request for 14 days free trial from before purchase:

Get more information:

We have also published some syndicated market research in a similar area that may be of interest to you. Below is the title of the report for your reference considering the impact of Covid-19 on this market, which will help you to assess the impact of the pandemic on the short term and long term growth trends of this market.

Similar reports:

Veterinary Imaging Services Market – Global Opportunity Analysis and Industry Forecast, 2020-2027

Veterinary Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2019-2027

Veterinary Ultrasound Market – Global Opportunity Analysis and Industry Forecast, 2019-2027

Veterinary / Animal Vaccines Market – Global Opportunity Analysis & Industry Forecast, 2019-2027

Veterinary Equipment and Disposables Market – Global Opportunity Analysis and Industry Forecast, 2019-2027

Veterinary Medicine Market – Global Opportunity Analysis and Industry Forecast, 2019-2027

Veterinary Radiography Market, Global Opportunity Analysis and Industry Forecast, 2019-2027

about us

Allied Market Research (AMR) is a full-service market research and management consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides unmatched quality of “market research reports” and “business intelligence solutions” to global corporations as well as medium and small businesses. AMR strives to provide business insights and advice to assist its clients with strategic business decisions and sustainable growth in their respective market areas.

We have professional corporate relationships with various companies and this helps us unearth market data which will help us create accurate research data tables and confirm the highest accuracy of our market forecasts. Allied market research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high data quality and help customers succeed in every possible way. All of the data contained in the reports we publish are extracted through primary interviews with top officials from leading companies in the affected domain. Our secondary data acquisition methodology includes extensive online and offline research and discussions with knowledgeable professionals and industry analysts.